Effects of Vitamin D and Calcium Supplementation on Heart Rate and Blood Pressure in Community-Dwelling Older Individuals
- Michael Pfeifer MD
- … show all 1 hide
Objectives: Vitamin D deficiency has been linked to hypertension and cardiovascular events in observational studies. It is unclear whether vitamin D and/or calcium supplementation can reduce blood pressure, and if so, by how much.
Methods: This prospective study was undertaken to test the influence of latitude, seasonal variations, possible threshold effects, and duration of vitamin D efficacy after cessation of therapy. Two hundred and forty-two healthy male and female subjects with a mean age of 77 ± 4 years and a 25-hydroxyvitamin D serum level below 75 nmol/l were recruited in Bad Pyrmont and Graz and were randomly assigned to two treatment groups: one group receiving 1,000 mg calcium per day (Ca) and the other group 1,000 mg calcium and 800 IU vitamin D (Ca + D) over 12 months. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) were measured under standardized conditions every 4 months. Statistical evaluation was carried out using the statistics software of IDV, Gauting (Test + Estimation, version 5.2, “CRO” Dr. Heinz and Partner, Vienna, Austria).
Results: We performed an intention-to-treat analysis and found the following results:
In the (Ca + D) group, 25-hydroxyvitamin D increased significantly (p < 0.01) from 57 ± 20 nmol/l at baseline (BL) to 84 ± 18 nmol/l at month 12 (M12), whereas in the (Ca) group, there was no change (54 ± 19 versus 55 ± 18 nmol/l). In the (Ca + D) group, SBP decreased significantly (p < 0.01) from 134 ± 17 mmHg at BL to 124 ± 14 mmHg at M12, whereas in the (Ca) group, there was no change (137 ± 17 versus 133 ± 16 mmHg). In the (Ca + D) group, DBP decreased significantly (p < 0.01) from 76 ± 7 mmHg at BL to 72 ± 7 mmHg at M12, whereas in the (Ca) group, there was no change (79 ± 8 versus 78 ± 9 mmHg). In the (Ca + D) group, HR decreased significantly (p < 0.01) from 74 ± 4 beats per minute at BL to 70 ± 4 beats per minute at M12, whereas in the (Ca) group, there was no change (74 ± 4 versus 75 ± 4 beats per minute).
In the (Ca + D) group, 25-hydroxyvitamin D increased significantly (p < 0.01) from 57 ± 20 nmol/l at baseline (BL) to 84 ± 18 nmol/l at month 12 (M12), whereas in the (Ca) group, there was no change (54 ± 19 versus 55 ± 18 nmol/l).
In the (Ca + D) group, SBP decreased significantly (p < 0.01) from 134 ± 17 mmHg at BL to 124 ± 14 mmHg at M12, whereas in the (Ca) group, there was no change (137 ± 17 versus 133 ± 16 mmHg).
In the (Ca + D) group, DBP decreased significantly (p < 0.01) from 76 ± 7 mmHg at BL to 72 ± 7 mmHg at M12, whereas in the (Ca) group, there was no change (79 ± 8 versus 78 ± 9 mmHg).
In the (Ca + D) group, HR decreased significantly (p < 0.01) from 74 ± 4 beats per minute at BL to 70 ± 4 beats per minute at M12, whereas in the (Ca) group, there was no change (74 ± 4 versus 75 ± 4 beats per minute).
Conclusion: Despite a relatively high inclusion criterion for vitamin D (75 nmol/l) and independent of latitude, we observed a significant reduction of blood pressure and heart rate after supplementation with vitamin D and calcium. This effect of nutritional supplements may be comparable to the efficiency of antihypertensive drugs.
- Hypponen E, Power C. Hypovitaminosis in British adults at age 45 years: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85:860–8.
- Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination. Am J Hypertens. 2007;20:713–9. CrossRef
- Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int. 2002;13:187–94. CrossRef
- Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworogger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9. CrossRef
- Schleithoff SS, Zitterman A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754–9.
- Langford HG, Nainby-Luxemoore JC, Melson JC, et al. Hyperparathyroidism is associated with hypertension and may be causal. Clin Res. 1980;28:333–8.
- Bogin E, Massry SC, Levi J, et al. Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest. 1982;69:1017–25. CrossRef
- Stefenelli T, Mayr H, Bergler-Klein J, et al. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med. 1993;95:197–202. CrossRef
- Hulter HN, Melby JC, Petersen JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens. 1986;4:360–70.
- Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168:1629–37. CrossRef
- Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–9. CrossRef
- Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–12. CrossRef
- Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007;167:1730–7. CrossRef
- Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systemic review and meta-analysis. J Hypertens. 2009;27:1948–54. CrossRef
- Pittas AG, Chung M, Trikalinos T, et al. Vitamin D and cardiometabolic outcomes: a systematic review. Ann Intern Med. 2010;152:307–14.
- Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86:1633–7. CrossRef
- Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and other parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009;20:315–22. CrossRef
- Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367:40–9. CrossRef
- Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846–54. CrossRef
- Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9. CrossRef
- Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52:828–32. CrossRef
- Wang L, Manson JE, Buring JE, Lee IM, Sesso HD. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008;51:1073–9. CrossRef
- Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168:1174–80. CrossRef
- Pilz S, Dobnig H, Fischer JE, et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke. 2008;39:2611–3. CrossRef
- Marniemi J, Alanen E, Impivaara O, et al. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis. 2005;15:188–97. CrossRef
- Scragg R, Khaw KT, Murphy S. Effects of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640–6.
- Krause R, Buhring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998;352:709–10. CrossRef
- Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women’s Health Initiative Randomized Trial. Hypertension. 2008;52:847–55. CrossRef
- Nemerovski CW, Dorsch MP, Simpson RU, Bone HG, Aaronson KD, Bleske BE. Vitamin D and cardiovascular disease. Pharmacotherapy. 2009;29:691–708. CrossRef
- Prentice A, Goldberg GR, Schoenmakers I. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008;88:500S–6.
- Jacobs DR, Steffen LM. Nutrients, foods and dietary patterns as exposures in research: a framework for food synergy. Am J Clin Nutr. 2003;78:508S–13.
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of serum 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28.
- Effects of Vitamin D and Calcium Supplementation on Heart Rate and Blood Pressure in Community-Dwelling Older Individuals
- Book Title
- Nutritional Influences on Bone Health
- Book Subtitle
- 8th International Symposium
- pp 343-349
- Print ISBN
- Online ISBN
- Springer London
- Copyright Holder
- Springer-Verlag London
- Additional Links
- Vitamin D deficiency
- Heart rate
- Blood pressure
- Calcium and vitamin D supplementation
- Randomized controlled trial (RCT)
- Industry Sectors
- eBook Packages
- Editor Affiliations
- ID1. , Department of Internal Medicine, Hirslanden Clinic/Bois Cerf
- ID2. , Human Nutrition Research Center on Aging, Tufts University
- ID3. , Nutrition and Science, Purdue University
- Michael Pfeifer MD (00331)
- Author Affiliations
- 00331. Institute of Clincal Osteology Bad Pyrmont and German Osteology Foundation, Am-Hylligen Born 7, Bad Pyrmont, Lower Saxony, 31812, Germany
To view the rest of this content please follow the download PDF link above.